What 720,000 adults reveal about artificial sweeteners and diabetes risk
Data from more than 720,000 adults suggest that long-term consumption of artificial sweeteners may not be metabolically neutral,…
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Tennis legend Serena Williams is speaking openly about her decision to use a GLP-1 weight-loss medication, adding her…
Protein craze can lead to better health if done right
It’s a question that Dr. Travis Wilkes gets asked every day by patients. It is something that Dr.…
Blood ketone threshold may help predict weight loss success
Researchers identify a practical blood ketone threshold linked to greater short-term weight loss, offering new insight into how…
Could GLP-1 Drugs Reduce Breast Cancer Risk?
GLP-1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention. As reported by The…
Canada approves generic version of Wegovy for weight loss
FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
Regulators issue warning on ads for unlicensed weight loss drugs – Chemist+Druggist
Regulators issue warning on ads for unlicensed weight loss drugs Chemist+DruggistNovo Nordisk moves to launch Wegovy tablet in China ScandasiaWhat…
Walking 6K, 12K or 18K steps a day? Fitness coach reveals how many pounds of fat you could lose
If you’re looking for a sustainable way to lose weight, the answer could be as simple as putting…
Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’
Despite the common perception that GLP-1 use is an easy way out for weight loss, the reality is…
A new wave of weight-loss therapies aims to be better than today’s GLP-1s
Last Updated: June 7, 2026 at 10:18 a.m. ETFirst Published: June 6, 2026 at 2:53 p.m. ET One of the…
Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…